Skip to main content
Premium Trial:

Request an Annual Quote

NCI Proteomics Office Inks MOUs with FDA, NHLBI

NEW YORK (GenomeWeb News) – The National Cancer Institute said today that it has struck two new partnerships, one with the National Heart, Lung, and Blood Institute and another with the Food and Drug Administration, to develop and support new proteomics research projects through its Office of Cancer Clinical Proteomics Research, or OCCPR.

Under one memorandum of understanding, OCCPR and NHLBI's Proteomics Center Program agreed to extend a collaboration under which the partners will share reagents and protocols and develop bioinformatics standards for studies that use proteomics tools to understand cancer and cardiovascular and lung diseases.

The NCI proteomics office also signed an MOU with the FDA to formally extend a collaboration with FDA's Office of In Vitro Diagnostic Device Evaluation and Safety.

Under this agreement, the partners will work on statistical experimental design, analytical validation of instruments, informatics, and biospecimen sample preparations, as they are related to clinical cancer diagnostics and cancer therapeutics.

OCCPR's core efforts include integrating proteomics technologies with publicly accessible data, reagents, reference materials, and analysis systems, with the larger aim of supporting cancer research. The office also manages the Clinical Proteomic Tumor Analysis Consortium and represents a network of Protein Characterization Centers that coordinate proteomics studies of genomically characterized cancer specimens.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.